Epoxyeicosatrienoic acids (EETs) are cytochrome P450-derived metabolites of
arachidonic acid. They are potent endogenous vasodilator compounds produce
d by vascular cells, and EET-induced vasodilation has been attributed to ac
tivation of vascular smooth muscle cell (SMC) K+ channels. However, in some
cells, EETs activate Ca2+ channels, resulting in Ca2+ influx and increased
intracellular Ca2+ concentration ([Ca2+](i)). We investigated whether EETs
also can activate Ca2+ channels in vascular SMC and whether the resultant
Ca2+ influx can influence vascular tone. The 4 EET regioisomers (1 mu mol/L
) increased porcine aortic SMC [Ca2+](i) by 52% to 81%, whereas arachidonic
acid, dihydroxyeicosatrienoic acids, and 15-hydroxyeicosatetraenoic acid (
1 mu mol/L) produced little effect. The increases in [Ca2+](i) produced by
14,15-EET were abolished by removal of extracellular Ca2+ and by pretreatme
nt with verapamil (10 mu mol/L), an inhibitor of voltage-dependent (L-type)
Ca2+ channels, 14,15-EET did not alter Ca2+ signaling induced by norepinep
hrine and thapsigargin. When administered to porcine coronary artery rings
precontracted with a thromboxane mimetic, 14,15-EET produced relaxation. Ho
wever, when administered to rings precontracted with acetylcholine or KCI,
14,15-EET produced additional contractions. In rings exposed to 10 mmol/L K
Cl, a concentration that did not affect resting ring tension, 14,15-EET pro
duced small contractions that were abolished by EGTA (3 mmol/L) or verapami
l (10 mu mol/L). These observations indicate that 14,15-EET enhances [Ca2+]
(i) influx in vascular SMC through voltage-dependent Ca2+ channels. This 14
,15-EET-induced increase in [Ca-i(2+)] can produce vasoconstriction and the
refore may act to modulate EET-induced vasorelaxation.